Loading company…
Budapest-based molecular diagnostics company providing HLA genotyping tests and software based on next-generation sequencing.
Founded in 2011 and headquartered in Budapest, Hungary, Omixon Biocomputing Ltd. develops molecular diagnostics for HLA genotyping using next-generation sequencing. Its products include the Holotype HLA assay and software for Illumina sequencers, NanoTYPE kits and the HoloGRAFT ONE test, sold to histocompatibility laboratories, transplant centers and research facilities. In 2023 the company reported revenue of HUF 4,495,332.20 and EBITDA of HUF 557,208.40. Its CEO is Attila Bérces.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in